AOMORI OLYMPUS CO., LTD.
Manufacturer adverse-event records for AOMORI OLYMPUS CO., LTD. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2020–2026 · mid-book · typical Death-code · balanced
Volume signature
AOMORI OLYMPUS CO., LTD. sits mid-pack on MAUDE volume
AOMORI OLYMPUS CO., LTD. accounts for 8,271 FDA MAUDE reports (#278 of 434, mid-book tercile). Death-coded event_type share is 0.45% (typical); Injury share 28.3% (balanced).
What the volume reading shows for AOMORI OLYMPUS CO., LTD.
The standout signal for AOMORI OLYMPUS CO., LTD. is filing volume: 8,271 adverse-event reports in FDA MAUDE (#278 of 434, mid-book). Death-coded event_type share sits at 0.45% (typical).
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for AOMORI OLYMPUS CO., LTD.. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 20 device types, led in this extract by Malfunction at 5,893 (71.2% of event_type total). Peak single-year volume reaches 2,329 reports across 7 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.